in business - awaiting regulatory approvals for insulin trials: kiran mazumdar shaw
Published 11 years ago • 17 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
7:16
kiran mazumdar-shaw on 'ease of doing business'
-
1:23
in business - strong q1 on good product mix: biocon
-
1:44
in business - bullish on branded formulation biz: kiran mazumdar shaw
-
1:08
will slowing inflation gains mean smaller rate cuts? | presented by cme group
-
5:38
kiran mazumdar shaw in conversation with bloomberg tv india 13july15
-
14:56
warren buffett’s $280 billion cash pile explained
-
47:20
wall street week 09/13/2024
-
33:55
judge boyd rejects plea and takes matters into her own hands!
-
2:15
ecb rate decision: policy makers cut again as inflation recedes
-
6:27
biocon founder on equality in india's biopharmaceutical sector
-
7:15
investigation reveals how investors made millions as steward health care system collapsed
-
8:50
biosimilars - the next big thing | kiran mazumdar shaw to et now
-
4:35
biocon's mazumdar-shaw hopeful as india's infections slow
-
7:20
investors still seeking exposure to credit: grewal
-
1:39:29
bloomberg open interest 09/12/2024
-
1:20
fed needs ‘crisp’ messaging on a 50 bps cut: blackrock’s lynam
-
8:43
in business- huge potential for manufacturing in india: kiran mazumdar shaw
-
5:01
these sectors could benefit most from a fed rate cut
-
1:32:13
china to cut rates on $5t of mortgages | bloomberg: the china show 9/13/2024
-
4:01
kiran mazumdar shaw speaks to et now about biocon receiving dgci approval for itolizumab
-
5:59
'fed has room to cut' by 50 bps: analyst
-
42:26
bloomberg brief (09/12/2024)